Metabolic diseases,such as diabetes,obesity,and steatotic liver disease,represent a global epidemic.The pathogenesis of these disorders involves systemic disturbances in glucose homeostasis,lipid metabolism,energy bal...Metabolic diseases,such as diabetes,obesity,and steatotic liver disease,represent a global epidemic.The pathogenesis of these disorders involves systemic disturbances in glucose homeostasis,lipid metabolism,energy balance,and inflammation,yet effective therapeutic strategies to correct these core disturbances remain limited.Silent information regulator 3(sirtuin 3(SIRT3)),a major mitochondrial deacetylase that we defined as the"head goose molecule,"acts as a central regulator and can initiate a coordinated rescue of metabolic homeostasis.We integrate evidence that SIRT3 activation triggers a"negentropic mechanism,"a suite of processes that collectively counteract systemic metabolic disorders by enhancing insulin sensitivity,promoting lipid oxidation,fine-tuning redox equilibrium,optimizing energy expenditure,and suppressing inflammation.The therapeutic potential of SIRT3 activators derived from natural products,synthetic compounds,and nicotinamide adenine dinucleotide(NAD+)precursors is evaluated,highlighting their promise as safe and sustainable treatment options.This review establishes the role of SIRT3 as a master regulator and suggests that it should be targeted to reconstitute systemic metabolic homeostasis.展开更多
Diabetic retinopathy(DR)is among the most prevalent microvascular complications of diabetes,with its onset and progression largely driven by chronic inflammation and mitochondrial dysfunction.In recent years,the nicot...Diabetic retinopathy(DR)is among the most prevalent microvascular complications of diabetes,with its onset and progression largely driven by chronic inflammation and mitochondrial dysfunction.In recent years,the nicotinamide adenine dinucleotide+dependent deacetylase family,sirtuins(SIRTs),has attracted growing attention for their integral roles in metabolic regulation,oxidative stress defense,inflammatory control,and cellular longevity.This review delineates the differential and stage-specific roles of SIRT isoforms in DR pathogenesis.SIRT1 attenuates inflammatory signaling by deacetylating key transcription factors,in-cluding nuclear factor-κB,and their target gene promoters,whereas the mitochon-dria-localized.SIRT3 directly deacetylates and activates antioxidant and metabolic enzymes to sustain reactive oxygen species balance and energy metabolism.Conversely,SIRT5 restores autophagic flux by desu-ccinylating optineurin at lysine-108,highlighting a novel link between post-translational modification and mitochondrial quality control.Accumulating preclinical evidence further indicates that various natural compounds and small-molecule activators,such as resveratrol,honokiol,and plant polyphenols,ameliorate DR-related pathology by upregulating SIRT signaling.By integrating current evidence,we highlight SIRTs as promising but complex therapeutic targets,underscoring the need for stage-specific intervention strategies and further research into less-explored isoforms to fully exploit their therapeutic potential.展开更多
Diabetic cardiomyopathy(DCM)is a cardiac muscle disorder that causes heart failure independently of coronary artery disease.This condition remains a major clinical challenge,as current therapies primarily address trad...Diabetic cardiomyopathy(DCM)is a cardiac muscle disorder that causes heart failure independently of coronary artery disease.This condition remains a major clinical challenge,as current therapies primarily address traditional risk factors rather than the underlying molecular pathology.In this regard,endothelial dysfunction in the cardiac microvasculature is a key factor in DCM,linking metabolic alterations to impaired myocardial perfusion and fibrosis.Ferroptosis is a unique form of iron-dependent,regulated cell death characterized by lipid peroxidation.This mechanism has been linked to various diabetic complications,although its role in chronic diabetic heart disease remains unclear.In this editorial,we discuss new evidence highlighting endothelial cell ferroptosis as a key mechanism in DCM and a promising therapeutic target.Specifically,we discuss the recent study by Guo et al,demonstrating that farrerol,a natural flavonoid,improves DCM in mice by inhibiting endothelial ferroptosis through the microRNA-29b-3p/sirtuin 1 signaling axis.The findings of Guo et al reveal that downregulation of microRNA-29b-3p by farrerol is able to restore sirtuin 1 levels in cardiac endothelial cells,activating antioxidant defenses and preventing ferroptotic injury.Importantly,the endothelial protection generated by Farrerol translated into improvements in cardiac function and a reduction in fibrosis in diabetic mice.These results open a new therapeutic opportunity for the treatment of DCM by targeting the cardiac microvascular endothelium.Future studies should build on this mechanistic knowledge,addressing the challenges of converting Farrerol,a natural compound with antioxidant and antiferroptotic properties,or other ferroptosis inhibitors into targeted therapies that safely benefit patients with diabetic heart disease.展开更多
The activation of the sirtuin1(SIRT1)uclear factor erythroid 2-related factor 2(Nrf2)/heme oxygenase 1(HO-1)pathway has been shown to mitigate oxidative stress-induced apoptosis and mitochondrial damage by reducing re...The activation of the sirtuin1(SIRT1)uclear factor erythroid 2-related factor 2(Nrf2)/heme oxygenase 1(HO-1)pathway has been shown to mitigate oxidative stress-induced apoptosis and mitochondrial damage by reducing reactive oxygen species(ROS)levels.Clinical trials have demonstrated that Zhongfeng Xingnao Liquid(ZFXN)ameliorates post-stroke cognitive impairment(PSCI).However,the underlying mechanism,particularly whether it involves protecting mitochondria and inhibiting apoptosis through the SIRT1/Nrf2/HO-1 pathway,remains unclear.This study employed an oxygen-glucose deprivation(OGD)cell model using SHSY5Y cells and induced PSCI in rats through modified bilateral carotid artery ligation(2VO).The effects of ZFXN on learning and memory,neuroprotective activity,mitochondrial function,oxidative stress,and the SIRT1/Nrf2/HO-1 pathway were evaluated both in vivo and in vitro.Results indicated that ZFXN significantly increased the B-cell lymphoma 2(Bcl2)/Bcl2-associated X(Bax)ratio,reduced terminal deoxynucleotidyl transferase-mediated d UTP nickend-labeling(TUNEL)+cells,and markedly improved cognition,synaptic plasticity,and neuronal function in the hippocampus and cortex.Furthermore,ZFXN exhibited potent antioxidant activity,evidenced by decreased ROS and malondialdehyde(MDA)content and increased superoxide dismutase(SOD),catalase(CAT),and glutathione(GSH)levels.ZFXN also demonstrated considerable enhancement of mitochondrial membrane potential(MMP),Tom 20 fluorescence intensity,adenosine triphosphate(ATP)and energy charge(EC)levels,and mitochondrial complexⅠandⅢactivity,thereby inhibiting mitochondrial damage.Additionally,ZFXN significantly increased SIRT1 activity and elevated SIRT1,nuclear Nrf2,and HO-1 levels.Notably,these effects were substantially counteracted when SIRT1 was suppressed by the inhibitor EX-527 in vitro.In conclusion,ZFXN alleviates PSCI by activating the SIRT1/Nrf2/HO-1 pathway and preventing mitochondrial damage.展开更多
Sirtuin 2 is a member of the sirtuin family nicotinamide adenine dinucleotide(NAD~+)-dependent deacetylases, known for its regulatory role in different processes, including inflammation. In this context, sirtuin 2 has...Sirtuin 2 is a member of the sirtuin family nicotinamide adenine dinucleotide(NAD~+)-dependent deacetylases, known for its regulatory role in different processes, including inflammation. In this context, sirtuin 2 has been involved in the modulation of key inflammatory signaling pathways and transcription factors by deacetylating specific targets, such as nuclear factor κB and nucleotide-binding oligomerization domain-leucine-rich-repeat and pyrin domain-containing protein 3(NLRP3). However, whether sirtuin 2-mediated pathways induce a pro-or an anti-inflammatory response remains controversial. Sirtuin 2 has been implicated in promoting inflammation in conditions such as asthma and neurodegenerative diseases, suggesting that its inhibition in these conditions could be a potential therapeutic strategy. Conversely, arthritis and type 2 diabetes mellitus studies suggest that sirtuin 2 is essential at the peripheral level and, thus, its inhibition in these pathologies would not be recommended. Overall, the precise role of sirtuin 2 in inflammation appears to be context-dependent, and further investigation is needed to determine the specific molecular mechanisms and downstream targets through which sirtuin 2 influences inflammatory processes in various tissues and pathological conditions. The present review explores the involvement of sirtuin 2 in the inflammation associated with different pathologies to elucidate whether its pharmacological modulation could serve as an effective strategy for treating this prevalent symptom across various diseases.展开更多
Acute lung injury(ALI)/acute respiratory distress syndrome(ARDS)is a severe clinical disorder characterized by widespread inflammation,diffuse alveolar damage,and pulmonary edema,often leading to respiratory failure a...Acute lung injury(ALI)/acute respiratory distress syndrome(ARDS)is a severe clinical disorder characterized by widespread inflammation,diffuse alveolar damage,and pulmonary edema,often leading to respiratory failure and death.Despite significant advances in clinical care,ALI/ARDS remains the leading cause of death among intensive care unit patients.Sepsis is the primary risk factor for the development of ALI/ARDS,as excessive inflammatory responses contribute to organ injury and high mortality in critically ill patients.展开更多
Sirtuin 3(SIRT3)is a primary mitochondrial deacetylase.Studies have confirmed that it directly activates mitophagy by modulating mitochondrial protein acetylation.As a key homeostatic mechanism,mitophagy activation al...Sirtuin 3(SIRT3)is a primary mitochondrial deacetylase.Studies have confirmed that it directly activates mitophagy by modulating mitochondrial protein acetylation.As a key homeostatic mechanism,mitophagy activation alleviates oxidative stress-induced imbalance between cell proliferation and apoptosis,corrects stress-driven mitochondrial metabolic dysfunction,and thus inhibits excessive tumor growth,exerting significant antitumor effects.These functions establish SIRT3 as a key target for regulating mitophagy and cancer therapy.Clinically,strategies centered on its precise regulation may offer a novel direction for gastric cancer(GC)prevention and treatment,with selective activation remaining a critical challenge.SIRT3 could also serve as an auxiliary indicator in clinical guidelines for assessing tumor progression.Given this potential,this minireview systematically examines SIRT3’s mechanisms in regulating mitophagy,its role in GC pathogenesis,and translational prospects for targeting SIRT3 in GC management.展开更多
BACKGROUND Hepatic ischemia reperfusion(HIR)injury is a major complication affecting various major liver surgeries,including liver transplantation.Aprepitant(APRE),a neurokinin-1 receptor antagonist,is commonly used a...BACKGROUND Hepatic ischemia reperfusion(HIR)injury is a major complication affecting various major liver surgeries,including liver transplantation.Aprepitant(APRE),a neurokinin-1 receptor antagonist,is commonly used as an antiemetic to prevent chemotherapy-induced nausea and vomiting.AIM To assess the potential protective effect of APRE against HIR-induced liver injury via targeting the nucleotide-binding oligomerization domain-,leucine-rich repeat-,and pyrin domain-containing receptor 3/interleukin(IL)-1beta signaling pathway.METHODS Six groups of adult male Wistar albino rats were divided as follows:Sham group,Sham/APRE10 group(APRE 10 mg/kg),HIR group,HIR/APRE5 group(APRE 5 mg/kg),HIR/APRE10 group(APRE 10 mg/kg),and HIR/APRE20 group(APRE 20 mg/kg).Serum alanine transaminase,aspartate transaminase,liver malondialdehyde,total antioxidant capacity levels,as well as IL-6,sirtuin 1(Sirt1),caspase-3,cleaved caspase-3,and tumor necrosis factor alpha biomarkers,were evaluated.Hepatic specimens were examined histopathologically and immunohistochemically for nuclear factor erythroid-2-related factor 2(Nrf2)immunoexpression.RESULTS HIR resulted in hepatic damage,as evidenced by histopathological changes and a significant increase in serum alanine transaminase,aspartate transaminase,hepatic malondialdehyde,caspase-3,and tumor necrosis factor alpha levels.Additionally,there were significant increases in hepatic total antioxidant capacity and reductions in IL-6 and cleaved caspase-3 protein levels,as demonstrated by Western blot analysis,along with enhanced immunoexpression of Sirt1 and Nrf2.APRE has significantly reduced various parameters of oxidative stress,inflammation,and apoptosis,and a significant increase in liver Nrf2 immunoexpression,leading to a significant improvement in the histopathological changes.CONCLUSION In conclusion,targeting the Sirt1/Nrf2 signaling pathway,as demonstrated by APRE in our model,could present a promising therapeutic target to protect against HIR-induced liver injury during major liver surgeries.展开更多
Ischemia-reperfusion injury(IRI)remains an unresolved and complicated situation in clinical practice,especially in the case of organ transplantation.Several factors contribute to its complexity;the depletion of energy...Ischemia-reperfusion injury(IRI)remains an unresolved and complicated situation in clinical practice,especially in the case of organ transplantation.Several factors contribute to its complexity;the depletion of energy during ischemia and the induction of oxidative stress during reperfusion initiate a cascade of pathways that lead to cell death and finally to severe organ injury.Recently,the sirtuin family of nicotinamide adenine dinucleotide-dependent deacetylases has gained increasing attention from researchers,due to their involvement in the modulation of a wide variety of cellular functions.There are seven mammalian sirtuins and,among them,the nuclear/cytoplasmic sirtuin 1(SIRT1)and the mitochondrial sirtuin 3(SIRT3)are ubiquitously expressed in many tissue types.Sirtuins are known to play major roles in protecting against cellular stress and in controlling metabolic pathways,which are key processes during IRI.In this review,we mainly focus on SIRT1 and SIRT3 and examine their role in modulating pathways against energy depletion during ischemia and their involvement in oxidative stress,apoptosis,microcirculatory stress and inflammation during reperfusion.We present evidence of the beneficial effects of sirtuins against IRI and emphasize the importance of developing new strategies by enhancing their action.展开更多
基金supported by the Beijing Natural Science Foundation(7252199)the National Natural Science Foundation of China(82304585)the CAMS Innovation Fund for Medical Sciences(2021-I2M-1-028 and 2021-I2M-1-009)。
摘要Metabolic diseases,such as diabetes,obesity,and steatotic liver disease,represent a global epidemic.The pathogenesis of these disorders involves systemic disturbances in glucose homeostasis,lipid metabolism,energy balance,and inflammation,yet effective therapeutic strategies to correct these core disturbances remain limited.Silent information regulator 3(sirtuin 3(SIRT3)),a major mitochondrial deacetylase that we defined as the"head goose molecule,"acts as a central regulator and can initiate a coordinated rescue of metabolic homeostasis.We integrate evidence that SIRT3 activation triggers a"negentropic mechanism,"a suite of processes that collectively counteract systemic metabolic disorders by enhancing insulin sensitivity,promoting lipid oxidation,fine-tuning redox equilibrium,optimizing energy expenditure,and suppressing inflammation.The therapeutic potential of SIRT3 activators derived from natural products,synthetic compounds,and nicotinamide adenine dinucleotide(NAD+)precursors is evaluated,highlighting their promise as safe and sustainable treatment options.This review establishes the role of SIRT3 as a master regulator and suggests that it should be targeted to reconstitute systemic metabolic homeostasis.
基金Supported by Quzhou Science and Technology Program Project,No.2022K69 and No.2025K049Henan Province Medical Science and Technology Research Program(Joint Construction),No.LHGJ20250403,No.LHGJ20220566,and No.LHGJ20240365+1 种基金Henan Provincial Key Research and Development Program,No.231111311000Henan Province Medical Education Research Project,No.WJLX2023079.
摘要Diabetic retinopathy(DR)is among the most prevalent microvascular complications of diabetes,with its onset and progression largely driven by chronic inflammation and mitochondrial dysfunction.In recent years,the nicotinamide adenine dinucleotide+dependent deacetylase family,sirtuins(SIRTs),has attracted growing attention for their integral roles in metabolic regulation,oxidative stress defense,inflammatory control,and cellular longevity.This review delineates the differential and stage-specific roles of SIRT isoforms in DR pathogenesis.SIRT1 attenuates inflammatory signaling by deacetylating key transcription factors,in-cluding nuclear factor-κB,and their target gene promoters,whereas the mitochon-dria-localized.SIRT3 directly deacetylates and activates antioxidant and metabolic enzymes to sustain reactive oxygen species balance and energy metabolism.Conversely,SIRT5 restores autophagic flux by desu-ccinylating optineurin at lysine-108,highlighting a novel link between post-translational modification and mitochondrial quality control.Accumulating preclinical evidence further indicates that various natural compounds and small-molecule activators,such as resveratrol,honokiol,and plant polyphenols,ameliorate DR-related pathology by upregulating SIRT signaling.By integrating current evidence,we highlight SIRTs as promising but complex therapeutic targets,underscoring the need for stage-specific intervention strategies and further research into less-explored isoforms to fully exploit their therapeutic potential.
摘要Diabetic cardiomyopathy(DCM)is a cardiac muscle disorder that causes heart failure independently of coronary artery disease.This condition remains a major clinical challenge,as current therapies primarily address traditional risk factors rather than the underlying molecular pathology.In this regard,endothelial dysfunction in the cardiac microvasculature is a key factor in DCM,linking metabolic alterations to impaired myocardial perfusion and fibrosis.Ferroptosis is a unique form of iron-dependent,regulated cell death characterized by lipid peroxidation.This mechanism has been linked to various diabetic complications,although its role in chronic diabetic heart disease remains unclear.In this editorial,we discuss new evidence highlighting endothelial cell ferroptosis as a key mechanism in DCM and a promising therapeutic target.Specifically,we discuss the recent study by Guo et al,demonstrating that farrerol,a natural flavonoid,improves DCM in mice by inhibiting endothelial ferroptosis through the microRNA-29b-3p/sirtuin 1 signaling axis.The findings of Guo et al reveal that downregulation of microRNA-29b-3p by farrerol is able to restore sirtuin 1 levels in cardiac endothelial cells,activating antioxidant defenses and preventing ferroptotic injury.Importantly,the endothelial protection generated by Farrerol translated into improvements in cardiac function and a reduction in fibrosis in diabetic mice.These results open a new therapeutic opportunity for the treatment of DCM by targeting the cardiac microvascular endothelium.Future studies should build on this mechanistic knowledge,addressing the challenges of converting Farrerol,a natural compound with antioxidant and antiferroptotic properties,or other ferroptosis inhibitors into targeted therapies that safely benefit patients with diabetic heart disease.
基金supported by the Science&Technology Department of Sichuan Province(No.2019YFS0040)the Improvement Plan of“Xinglin Scholar”Scientific Research Talent,Chengdu University of Traditional Chinese Medicine(No.XKTD2022002)。
摘要The activation of the sirtuin1(SIRT1)uclear factor erythroid 2-related factor 2(Nrf2)/heme oxygenase 1(HO-1)pathway has been shown to mitigate oxidative stress-induced apoptosis and mitochondrial damage by reducing reactive oxygen species(ROS)levels.Clinical trials have demonstrated that Zhongfeng Xingnao Liquid(ZFXN)ameliorates post-stroke cognitive impairment(PSCI).However,the underlying mechanism,particularly whether it involves protecting mitochondria and inhibiting apoptosis through the SIRT1/Nrf2/HO-1 pathway,remains unclear.This study employed an oxygen-glucose deprivation(OGD)cell model using SHSY5Y cells and induced PSCI in rats through modified bilateral carotid artery ligation(2VO).The effects of ZFXN on learning and memory,neuroprotective activity,mitochondrial function,oxidative stress,and the SIRT1/Nrf2/HO-1 pathway were evaluated both in vivo and in vitro.Results indicated that ZFXN significantly increased the B-cell lymphoma 2(Bcl2)/Bcl2-associated X(Bax)ratio,reduced terminal deoxynucleotidyl transferase-mediated d UTP nickend-labeling(TUNEL)+cells,and markedly improved cognition,synaptic plasticity,and neuronal function in the hippocampus and cortex.Furthermore,ZFXN exhibited potent antioxidant activity,evidenced by decreased ROS and malondialdehyde(MDA)content and increased superoxide dismutase(SOD),catalase(CAT),and glutathione(GSH)levels.ZFXN also demonstrated considerable enhancement of mitochondrial membrane potential(MMP),Tom 20 fluorescence intensity,adenosine triphosphate(ATP)and energy charge(EC)levels,and mitochondrial complexⅠandⅢactivity,thereby inhibiting mitochondrial damage.Additionally,ZFXN significantly increased SIRT1 activity and elevated SIRT1,nuclear Nrf2,and HO-1 levels.Notably,these effects were substantially counteracted when SIRT1 was suppressed by the inhibitor EX-527 in vitro.In conclusion,ZFXN alleviates PSCI by activating the SIRT1/Nrf2/HO-1 pathway and preventing mitochondrial damage.
基金funded by FEDER/Ministerio de Ciencia,Innovación y Universidades Agencia Estatal de Investigación/Project(PID2020-119729GB-100,REF/AEI/10.13039/501100011033)(to EP)a predoctoral fellowship from the Spanish Ministry of Universities(FPU)and Amigos de la Universidad de Navarra(to NSS)“Programa MRR Investigo 2023”(to MGB and MMD)。
摘要Sirtuin 2 is a member of the sirtuin family nicotinamide adenine dinucleotide(NAD~+)-dependent deacetylases, known for its regulatory role in different processes, including inflammation. In this context, sirtuin 2 has been involved in the modulation of key inflammatory signaling pathways and transcription factors by deacetylating specific targets, such as nuclear factor κB and nucleotide-binding oligomerization domain-leucine-rich-repeat and pyrin domain-containing protein 3(NLRP3). However, whether sirtuin 2-mediated pathways induce a pro-or an anti-inflammatory response remains controversial. Sirtuin 2 has been implicated in promoting inflammation in conditions such as asthma and neurodegenerative diseases, suggesting that its inhibition in these conditions could be a potential therapeutic strategy. Conversely, arthritis and type 2 diabetes mellitus studies suggest that sirtuin 2 is essential at the peripheral level and, thus, its inhibition in these pathologies would not be recommended. Overall, the precise role of sirtuin 2 in inflammation appears to be context-dependent, and further investigation is needed to determine the specific molecular mechanisms and downstream targets through which sirtuin 2 influences inflammatory processes in various tissues and pathological conditions. The present review explores the involvement of sirtuin 2 in the inflammation associated with different pathologies to elucidate whether its pharmacological modulation could serve as an effective strategy for treating this prevalent symptom across various diseases.
基金supported by National Natural Science Foundation of China(82471792,82270004,81870061,82202382,31770945)Beijing Municipal Natural Science Foundation(7242135)Zhejiang Provincial Natural Science Foundation(LY20H010003).
摘要Acute lung injury(ALI)/acute respiratory distress syndrome(ARDS)is a severe clinical disorder characterized by widespread inflammation,diffuse alveolar damage,and pulmonary edema,often leading to respiratory failure and death.Despite significant advances in clinical care,ALI/ARDS remains the leading cause of death among intensive care unit patients.Sepsis is the primary risk factor for the development of ALI/ARDS,as excessive inflammatory responses contribute to organ injury and high mortality in critically ill patients.
摘要Sirtuin 3(SIRT3)is a primary mitochondrial deacetylase.Studies have confirmed that it directly activates mitophagy by modulating mitochondrial protein acetylation.As a key homeostatic mechanism,mitophagy activation alleviates oxidative stress-induced imbalance between cell proliferation and apoptosis,corrects stress-driven mitochondrial metabolic dysfunction,and thus inhibits excessive tumor growth,exerting significant antitumor effects.These functions establish SIRT3 as a key target for regulating mitophagy and cancer therapy.Clinically,strategies centered on its precise regulation may offer a novel direction for gastric cancer(GC)prevention and treatment,with selective activation remaining a critical challenge.SIRT3 could also serve as an auxiliary indicator in clinical guidelines for assessing tumor progression.Given this potential,this minireview systematically examines SIRT3’s mechanisms in regulating mitophagy,its role in GC pathogenesis,and translational prospects for targeting SIRT3 in GC management.
摘要BACKGROUND Hepatic ischemia reperfusion(HIR)injury is a major complication affecting various major liver surgeries,including liver transplantation.Aprepitant(APRE),a neurokinin-1 receptor antagonist,is commonly used as an antiemetic to prevent chemotherapy-induced nausea and vomiting.AIM To assess the potential protective effect of APRE against HIR-induced liver injury via targeting the nucleotide-binding oligomerization domain-,leucine-rich repeat-,and pyrin domain-containing receptor 3/interleukin(IL)-1beta signaling pathway.METHODS Six groups of adult male Wistar albino rats were divided as follows:Sham group,Sham/APRE10 group(APRE 10 mg/kg),HIR group,HIR/APRE5 group(APRE 5 mg/kg),HIR/APRE10 group(APRE 10 mg/kg),and HIR/APRE20 group(APRE 20 mg/kg).Serum alanine transaminase,aspartate transaminase,liver malondialdehyde,total antioxidant capacity levels,as well as IL-6,sirtuin 1(Sirt1),caspase-3,cleaved caspase-3,and tumor necrosis factor alpha biomarkers,were evaluated.Hepatic specimens were examined histopathologically and immunohistochemically for nuclear factor erythroid-2-related factor 2(Nrf2)immunoexpression.RESULTS HIR resulted in hepatic damage,as evidenced by histopathological changes and a significant increase in serum alanine transaminase,aspartate transaminase,hepatic malondialdehyde,caspase-3,and tumor necrosis factor alpha levels.Additionally,there were significant increases in hepatic total antioxidant capacity and reductions in IL-6 and cleaved caspase-3 protein levels,as demonstrated by Western blot analysis,along with enhanced immunoexpression of Sirt1 and Nrf2.APRE has significantly reduced various parameters of oxidative stress,inflammation,and apoptosis,and a significant increase in liver Nrf2 immunoexpression,leading to a significant improvement in the histopathological changes.CONCLUSION In conclusion,targeting the Sirt1/Nrf2 signaling pathway,as demonstrated by APRE in our model,could present a promising therapeutic target to protect against HIR-induced liver injury during major liver surgeries.
基金Supported by AGAUR,No.2012FI_B00382,Generalitat de Catalunya,Barcelona,Spain,to Pantazi ECSIC for the development program to Bejaoui M,No.I-COOP0005The Fondo de Investigaciones Sanitarias,No.FIS PI12/00519
摘要Ischemia-reperfusion injury(IRI)remains an unresolved and complicated situation in clinical practice,especially in the case of organ transplantation.Several factors contribute to its complexity;the depletion of energy during ischemia and the induction of oxidative stress during reperfusion initiate a cascade of pathways that lead to cell death and finally to severe organ injury.Recently,the sirtuin family of nicotinamide adenine dinucleotide-dependent deacetylases has gained increasing attention from researchers,due to their involvement in the modulation of a wide variety of cellular functions.There are seven mammalian sirtuins and,among them,the nuclear/cytoplasmic sirtuin 1(SIRT1)and the mitochondrial sirtuin 3(SIRT3)are ubiquitously expressed in many tissue types.Sirtuins are known to play major roles in protecting against cellular stress and in controlling metabolic pathways,which are key processes during IRI.In this review,we mainly focus on SIRT1 and SIRT3 and examine their role in modulating pathways against energy depletion during ischemia and their involvement in oxidative stress,apoptosis,microcirculatory stress and inflammation during reperfusion.We present evidence of the beneficial effects of sirtuins against IRI and emphasize the importance of developing new strategies by enhancing their action.